Japanese IT Stock News

Astellas Pharma (TSE:4503) is back in the spotlight as it prepares to share new results in both oncology and ophthalmology at major medical conferences. The recent reimbursement for VYLOY in Canada also broadens potential commercial returns. See our latest analysis for Astellas Pharma. With fresh reimbursement wins for VYLOY and major new oncology data heading to ESMO, momentum around Astellas Pharma is building. While the 90-day share price return stands at 15.25%, recent performance has...

Sony Financial Group (TSE:8729) has captured attention following its announcement of a major share buyback initiative, along with recent shifts in its index status. These moves are sparking fresh conversations about the stock’s overall appeal. See our latest analysis for Sony Financial Group. It’s been a volatile few weeks for Sony Financial Group, with a flurry of share buyback announcements and rapid shifts in its index listings sending mixed signals to investors. After a tough year-to-date...

In the past week, INPEX Corporation announced it acquired 4,788,600 of its own shares through market purchases on the Tokyo Stock Exchange, as part of a buyback program targeting up to 50 million shares by the end of 2025. This ongoing share repurchase initiative highlights INPEX’s active capital management and its intention to potentially enhance shareholder value amid an evolving energy sector. We’ll examine how INPEX’s renewed commitment to buybacks could impact its investment narrative...

OSG (TSE:6136) continues to draw investor interest as it trends higher over the past month, not because of a fresh headline event but due to its solid performance and steady growth metrics. See our latest analysis for OSG. Momentum has clearly been building for OSG, with the share price delivering a 7.99% return over the past month and extending to a hefty 21.71% return year-to-date. Even more impressively, OSG's total shareholder return of nearly 30% over the past year highlights how...

Kura Oncology and Kyowa Kirin recently announced the initiation of two global, randomized Phase 3 clinical trials evaluating ziftomenib, an investigational oral menin inhibitor, in combination with standard therapies for newly diagnosed patients with specific genetic mutations in acute myeloid leukemia (AML). Ziftomenib is currently the only menin inhibitor to receive Breakthrough Therapy Designation from the FDA for relapsed or refractory NPM1-mutated AML, underscoring its potential to...

Nippon Shokubai (TSE:4114) just wrapped up its latest share buyback initiative, acquiring more than 2.8 million shares from late July through September. This move often draws attention from investors who are considering longer-term value. See our latest analysis for Nippon Shokubai. This buyback concludes at a time when Nippon Shokubai’s share price has swung lower in recent weeks. However, the three-year total shareholder return stands at more than 53%, suggesting that the company’s steady...

Matsuya (TSE:8237) recorded a net profit margin of 0.9% for the twelve months ending August 31, 2025, a sharp drop from 7.2% the previous year. Profitability was hit by a one-off loss of ¥1.4 billion, despite the company’s average earnings growth of 41.4% per year over the past five years. Meanwhile, Matsuya’s shares currently trade at a Price-to-Sales ratio of 1.8x, well above both the industry and peer averages. This could weigh on investor sentiment as margins compress. See our full...

Marubeni Corp. recently established Marubeni Power Trading, a new joint venture with its subsidiary SmartestEnergy Ltd., to expand into Japan’s liberalized power market through spot and futures trading of electricity and fuels. This move highlights Marubeni’s intent to leverage growing power demand from artificial intelligence and data center expansion, as well as the region’s increasingly active derivatives markets. We’ll explore how establishing Marubeni Power Trading supports the...

Nippon BS Broadcasting (TSE:9414) reported a net profit margin of 11.4%, just below last year’s 11.9%, while earnings have been on a downward trend, falling 4.9% per year over the past five years and showing another decline in the most recent period. Despite these headwinds, the stock’s Price-To-Earnings ratio is 13x, which stands lower than peers (15.7x) and the broader Japanese media sector (17.7x), with shares trading at ¥981, well under the fair value estimate of ¥2,616.13. The results...

With its stock down 10% over the past three months, it is easy to disregard Hamamatsu Photonics K.K (TSE:6965). We...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Kajima fair value estimate is JP¥5,246 Kajima's JP¥4,450 share...

Mabuchi Motor Co., Ltd. recently completed a buyback of 2,839,400 shares for ¥6,218.79 million and established a new wholly owned subsidiary, Mabuchi Motor Engineering Co., Ltd., to enhance its design and manufacturing capabilities. By investing in in-house engineering capacity and completing its share repurchase program, the company aims to support future product diversification and integration of past acquisitions. We'll explore how expanding in-house design and manufacturing through...

Japaniace Co.,Ltd. ( TSE:9558 ) will increase its dividend from last year's comparable payment on the 25th of February...

When close to half the companies in Japan have price-to-earnings ratios (or "P/E's") below 14x, you may consider Fujimi...

LIKE, Inc.'s ( TSE:2462 ) investors are due to receive a payment of ¥30.00 per share on 10th of February. This will...

The board of CL Holdings Inc. ( TSE:4286 ) has announced that it will be paying its dividend of ¥16.00 on the 31st of...

The board of Satori Electric Co., Ltd. ( TSE:7420 ) has announced that it will pay a dividend on the 16th of February...

Japan Excellent, Inc. has announced a semi-annual dividend of ¥3,000 per share, scheduled for payment on March 23, 2026, with the ex-date set for December 29, 2025 and a record date of December 31, 2025. This increase signals the company's confidence in its earnings stability and commitment to prioritizing shareholder returns through enhanced dividend payouts. We'll examine how this commitment to higher dividends shapes Japan Excellent's current investment narrative and outlook for reliable...

Bridgestone (TSE:5108) has caught investors’ attention lately as the company leans into operational restructuring in Europe and Latin America. With ongoing efforts to streamline production and distribution, many are watching for positive impacts on future profitability. See our latest analysis for Bridgestone. Bridgestone’s momentum is hard to miss, as its 27.3% year-to-date share price return has outpaced much of the market, fueled by improving earnings, major buybacks, and fresh product...

These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But one can do...

Key Insights The projected fair value for Isetan Mitsukoshi Holdings is JP¥2,459 based on 2 Stage Free Cash Flow to...

The board of Amita Holdings Co.,Ltd. ( TSE:2195 ) has announced that it will be paying its dividend of ¥5.00 on the...

By buying an index fund, you can roughly match the market return with ease. But many of us dare to dream of bigger...